BillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™, the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy test, Northstar, that combines treatment selection with monitoring. To date, over 500,000 patients have benefited from our innovative and precise diagnostic tests, and our Annual Recurring Revenue (ARR) has grown from $0 to $125 million in the last ~4 years.
BillionToOne has successfully raised close to $400 million in funding, with a notable $130 million Series D round completed in June 2024, resulting in a company valuation of over $1 billion. This funding has come from prestigious global institutional investors, including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. BillionToOne has recently been recognized by Forbes as one of America's Best Startup Employers for 2024, highlighting the company's exceptional work environment and commitment to innovation.
Our team has grown significantly and despite substantial growth, we have successfully maintained the unique culture that has defined BillionToOne from inception, continuing to cultivate a team that is not only diverse and passionate but also innovative. Headquartered in Menlo Park, California, with an additional facility in Union City, California, BillionToOne remains at the forefront of significant advances in molecular diagnostics, evidenced by the recent announcement of clinical outcomes data for its Unity Fetal Risk Screen and new advancements in cancer diagnostics. For more detailed information about BillionToOne and its groundbreaking work, please visit our website at www.billiontoone.com.
We are seeking a dynamic and experienced Senior FP&A Manager to enhance our growing team, focusing primarily on supporting Lab Operations and Medical/R&D. In this strategic position, you will lead the development of Long-range plan, Annual Operating plan, quarterly forecasts, and management reports, while performing ad hoc business analysis. Your role will be crucial in delivering financial insights and reports to key stakeholders across the organization, ensuring alignment with our strategic objectives. We are looking for a strategic thinker with strong analytical skills, excellent communication, and a passion for molecular diagnostics. This role requires collaboration with the leadership team and key budget stakeholders, and will report to the Senior Director of FP&A.
Core Responsibilities:
- Act as a strategic financial business partner to multiple functional groups, delivering strategic and financial guidance on operating expense budgets and forecasts, conducting detailed variance analyses, and offering insights and recommendations to optimize business decisions.
- Lead the Long-Range Plan, annual and semi-annual Operating Plans, and Reforecasts through accurate and timely completion
- Perform comprehensive analyses of operating and personnel expenses to identify trends, opportunities, and risks.
- Co-administer the financial planning and budgeting software, including ongoing data quality control, module enhancements, and user guidance and training
- Develop accurate, comprehensive slide materials for the Annual Operating Plan, Forecasts, and Board of Directors meetings, and other executive meetings
- Continually seek to streamline financial planning processes, reporting standards, and KPIs to enhance decision-making and operational efficiency
- Drive efficiencies by integrating best practices across all financial planning and analysis activities
- Identify and lead process improvement initiatives, maintaining a holistic view of organizational impacts and enhancing overall efficiency
- Proactively identify, lead, and execute projects that communicate actionable financial and business insights to senior leadership
- Ensure that all expenses are accurately accounted for during month-end close processes, in compliance with GAAP standards
- Serve as a key resource for resolving accounting and finance-related issues, offering guidance to internal stakeholders
- Actively contribute to FP&A team objectives, promoting a collaborative and productive work environment.
Requirements:
- 10+ years of progressive experience in FP&A
- Experience in diagnostics, life sciences, and/or biotechnology industries is strongly preferred
- Bachelor's degree in Finance, Economics, or a related field; MBA preferred
- Highly motivated self-starter with strong analytical, interpersonal, and time management skills
- Strong oral and written communication skills
- Strong attention to detail and accuracy
- Ability to collaborate with the executive team in a senior financial role
- Ability to work effectively and communicate cross-functionally at all organization levels
- A natural curiosity and desire to drive more efficient business procedures
- Experience using Planful and NetSuite is highly desired
- Proficiency in building and utilizing financial models and retrieving financial data
- Expert-level skills in Excel and advanced proficiency with business applications, including the MS Office Suite
- Knowledge of GAAP and financial accounting processes, with prior hands-on experience in financial closing activities
- Ability to provide and receive feedback professionally
- Hybrid work schedule with onsite presence in Menlo Park at least two days a week
Benefits And Perks:
- Working with a team of ‘rockstars’ who bring out the best in everyone
- Open, transparent culture that includes weekly Town Hall meetings
- The ability to indirectly or directly change the lives of hundreds of thousands patients
- Multiple medical benefit options; employee premiums paid 100% of select plans, dependents covered at 80%
- Extremely generous Family Bonding Leave for new parents (16 weeks, paid at 100%)
- Retirement savings program including a 4% Company match
- Free daily on-site lunches provided from top eateries
- Latest and greatest hardware (laptop, lab equipment, facilities)
- A variety of perks on campus (state of the art gym, restaurant)
- Free on-site EV charging (compatible with all EVs, including Tesla)
At BillionToOne, we are proud to offer a combination of a (1) base pay range (actual amount offered is based on experience and salary/equity options split that the candidate chooses), (2) generous equity options offering, (3) corporate bonus program, on top of (4) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave, etc.).
For this position, we offer a total compensation package of $303,870 per year, including a base pay range of $173,400 - $193,800 per year.
BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
For more information about how we protect your information, we encourage you to review our Privacy Policy.
Top Skills
What We Do
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending molecular counter platform is the only technology platform that can accurately count the DNA molecules at the single-count level.
